Fecal microbial transplantation (FMT) as an alternative treatment for recurrent Clostridium difficile infection (RCDI)

Main Article Content

Anam Qudrat

Keywords

Bacteriotherapy, Fecal Microbial Transplantation (FMT), Clostridium Difficile Infection (CDI), Recurrent Clostridium Difficile Infection (RCDI)

Abstract

Clostridium difficile infection (CDI) is a bacterial infection, most often contracted in the hospital. Causing mild diarrhoea to severe gut inflammation, it has become an emerging epidemic in the last decade. As the infection rate increases alarmingly, it becomes a burden on patients and their healthcare providers to manage. Coupled with this increase is the imminent threat of recurring episodes, termed recurrent Clostridium difficile infection (RCDI). As hypervirulent strains evade conventional drug therapies, investment in fecal microbial transplantation (FMT) as a viable alternative is being made. Here, we survey this procedure, its current efficacy and future prospects.